Lucia Laugwitz,Fubo Cheng,Stephan C Collins,Alexander Hustinx,Nicolas Navarro,Simon Welsch,Helen Cox,Tzung-Chien Hsieh,Aswinkumar Vijayananth,Rebecca Buchert,Benjamin Bender,Stephanie Efthymiou,David Murphy,Faisal Zafar,Nuzhat Rana,Ute Grasshoff,Ruth J Falb,Mona Grimmel,Annette Seibt,Wenxu Zheng,Hamid Ghaedi,Marie Thirion,Sébastien Couette,Reza Azizimalamiri,Saeid Sadeghian,Hamid Galehdari,Mina Zamani,Jawaher Zeighami,Alireza Sedaghat,Samira Molaei Ramshe,Ali Zare,Behnam Alipoor,Dirk Klee,Marc Sturm,Stephan Ossowski,Henry Houlden,Olaf Riess,Dagmar Wieczorek,Ryan Gavin,Reza Maroofian,Peter Krawitz,Binnaz Yalcin,Felix Distelmaier,Tobias B Haack

Abstract:Neurodevelopmental disorders are major indications for genetic referral and have been linked to more than 1,500 loci including genes encoding transcriptional regulators. The dysfunction of transcription factors often results in characteristic syndromic presentations, however, at least half of these patients lack a genetic diagnosis. The implementation of machine learning approaches has the potential to aid in the identification of new disease genes and delineate associated phenotypes. Next generation sequencing was performed in seven affected individuals with neurodevelopmental delay and dysmorphic features. Clinical characterization included reanalysis of available neuroimaging datasets and 2D portrait image analysis with GestaltMatcher. The functional consequences of ZSCAN10 loss were modelled in mouse embryonic stem cells (mESC), including a knock-out and a representative ZSCAN10 protein truncating variant. These models were characterized by gene expression and Western blot analyses, chromatin immunoprecipitation and quantitative PCR (ChIP-qPCR), and immunofluorescence staining. Zscan10 knockout mouse embryos were generated and phenotyped. We prioritized bi-allelic ZSCAN10 loss-of-function variants in seven affected individuals from five unrelated families as the underlying molecular cause. RNA-Seq analyses in Zscan10 -/- mESCs indicated dysregulation of genes related to stem cell pluripotency. In addition, we established in mESCs the loss-of-function mechanism for a representative human ZSCAN10 protein truncating variant by showing alteration of its expression levels and subcellular localization, interfering with its binding to DNA enhancer targets. Deep phenotyping revealed global developmental delay, facial asymmetry, and malformations of the outer ear as consistent clinical features. Cerebral MRI showed dysplasia of the semicircular canals as an anatomical correlate of sensorineural hearing loss. Facial asymmetry was confirmed as a clinical feature by GestaltMatcher and was recapitulated in the Zscan10 mouse model along with inner and outer ear malformations. Our findings provide evidence of a novel syndromic neurodevelopmental disorder caused by bi-allelic loss-of-function variants in ZSCAN10 .

Further delineation of the SCAF4 -associated neurodevelopmental disorder

Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

Expanding the phenotypic spectrum of TRAF7 -related CAFDADD: report of eleven new cases and literature review.

Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities

Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures

Further description of two individuals with de novo p.(Glu127Lys) missense variant in the ASCL1 gene

Identification of an Identical De Novo SCAMP5 Missense Variant in Four Unrelated Patients with Seizures and Severe Neurodevelopmental Delay.

Phenotypic spectrum associated with CASK loss-of-function mutations

SCYL2‐related autosomal recessive neurodevelopmental disorders: Arthrogryposis multiplex congenita‐4 and beyond?

Expanding the genetic and phenotypic relevance of CLCN4 variants in neurodevelopmental condition: 13 new patients

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

De novo SCAMP5 mutation causes a neurodevelopmental disorder with autistic features and seizures

Biallelic Variants in PCDHGC4 Cause a Novel Neurodevelopmental Syndrome with Progressive Microcephaly, Seizures, and Joint Anomalies.

Broadening the phenotypic and molecular spectrum of FINCA syndrome: Biallelic NHLRC2 variants in 15 novel individuals

A Novel Frameshift CHD4 Variant Leading to Sifrim-Hitz-Weiss Syndrome in a Proband with a Subclinical Familial t(17;19) and a Large dup(2)(q14.3q21.1)

Bi-allelic loss-of-function variants in BCAS3 cause a syndromic neurodevelopmental disorder

Widening of the genetic and clinical spectrum of Lamb-Shaffer syndrome, a neurodevelopmental disorder due to SOX5 haploinsufficiency

Further delineation of the rare GDACCF (global developmental delay, absent or hypoplastic corpus callosum, dysmorphic facies syndrome): genotype and phenotype of 22 patients with ZNF148 mutations

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants

ZSCAN10 deficiency causes a neurodevelopmental disorder with characteristic oto-facial malformations